Skip to content

Medical-device intelligence

DIO: Enzyme Immunoassay, Cocaine And Cocaine Metabolites

FDA product code DIO: Enzyme Immunoassay, Cocaine And Cocaine Metabolites. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DIO
FDA device name
Enzyme Immunoassay, Cocaine And Cocaine Metabolites
Device class
2
Regulation number
862.3250
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

145 clearance records and 23 recall records in the covered releases, across 76 source company names and 1 product codes. Dated history runs from Mar 19, 1984 to Jan 27, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
DIO · Enzyme Immunoassay, Cocaine And Cocaine Metabolites14523

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

168 matching records
Device / recordCompany in FDA recordSourceSource date
REDI-TEST COCAINEK991110 · DIORedwood Biotech, Inc.510(k)Jul 26, 1999FDA decision date
QUIKSTRIP ONE STEP COCAINE ASSAY (COCAINE AND COCAINE METABOLITE TEST SYSTEMK992207 · DIOSyntron Bioresearch, Inc.510(k)Jul 22, 1999FDA decision date
RAPIDONE - COCAINE TESTK990822 · DIOAmerican Bio Medica Corp.510(k)Jul 15, 1999FDA decision date
MODIFICATION TO ABUSCREEN ONLINE COCAINE METABOLITEK983697 · DIORoche Diagnostic Systems, Inc.510(k)Dec 11, 1998FDA decision date
AUTO-LYTE COCAINE METABOLITE EIA, MODEL # 1222UK982759 · DIOOraSure Technologies, Inc.510(k)Nov 20, 1998FDA decision date
DBEST COCAINE TEST KITK983191 · DIOAmeritek, Inc.510(k)Nov 18, 1998FDA decision date
ONTRAK TESTCUP-ERK983388 · DIORoche Diagnostic Systems, Inc.510(k)Nov 18, 1998FDA decision date
STC COCAINE METABOLITE MICRO-PLATE EIA (ORASURE DEVICE)K982061 · DIOOraSure Technologies, Inc.510(k)Aug 25, 1998FDA decision date
MICRO-STRIP FOR COCAINE METABOLITESK981388 · DIOMicrodiagnostics, Inc.510(k)May 29, 1998FDA decision date
MECTESTK973986 · DIOMeco Industries510(k)Apr 24, 1998FDA decision date
DRUG CHECKK980153 · DIOTexas Immunology, Inc.510(k)Mar 27, 1998FDA decision date
RAPID DRUG SCREEN' 8 PANELK980872 · DIOAmerican Bio Medica Corp.510(k)Mar 20, 1998FDA decision date
STC COCAINE METABOLITE MICRO-PLATE EIAK973651 · DIOOraSure Technologies, Inc.510(k)Jan 2, 1998FDA decision date
QUIKPAC II ONE STEP COCAINE TESTK972059 · DIODrial Consultants, Inc.510(k)Aug 28, 1997FDA decision date
AQ ONE STEP COCAINE TESTK972384 · DIOBionike Laboratories, Inc.510(k)Aug 6, 1997FDA decision date
QUIKSTRIP ONE STEP COCAINE TESTK971926 · DIODrial Consultants, Inc.510(k)Jul 14, 1997FDA decision date
RAPID DRUG SCREENK964900 · DIOAmerican Bio Medica Corp.510(k)Apr 14, 1997FDA decision date
IMMULITE COCAINE METABOLITEK963918 · DIODiagnostic Products Corp.510(k)Apr 8, 1997FDA decision date
ACCUSIGN DOA 5 (THC/OPI/COC/MET OR AMP/PCP)K962353 · DIOPrinceton BioMeditech Corp.510(k)Aug 19, 1996FDA decision date
COCAINE METABOLITE EIA TESTK960187 · DIODiagnostic Reagents, Inc.510(k)Apr 2, 1996FDA decision date
FRONTLINE COCAINEK954496 · DIOBoehringer Mannheim Corp.510(k)Mar 6, 1996FDA decision date
ABUSIGN DOA 3, DOA, COC/THC/OPI, ACCUSIGN DOA 3, BIOSIGN DOA 3, COC/THC/OOPIK954571 · DIOPrinceton BioMeditech Corp.510(k)Nov 3, 1995FDA decision date
ABUSIGN(TM) DOA 4, DOA, THC/OPI/COC/AMP OR MET, BIOSIGN(TM) DOA 4, THC/OPI/COC/AMP OR METK945549 · DIOPrinceton BioMeditech Corp.510(k)Oct 26, 1995FDA decision date
ABUSIGN DOA 2, DOA, COC/THC, DOA2, BIOSIGN DOA2, COC/THCK952361 · DIOPrinceton BioMeditech Corp.510(k)Oct 26, 1995FDA decision date
MECTESTK945207 · DIOMeco Industries510(k)Sep 25, 1995FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗